The p16INK4a tumour suppressor gene encodes a cyclin-dependent kinase inhibitor, preferentially binding to CDK4 and CDK6, preventing the coupling of those kinases with d-type cyclins and thus the activating phosphorylation of Rb. This evidence concerns the gene CDKN2A and neoplasm.